Patient-derived tumour xenografts as models for oncology drug development

Lignende værker

• Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
  af: Bagby, Stacey, et al.
  Udgivet: (2016)
• Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts
  af: Lieu, Christopher H., et al.
  Udgivet: (2015)
• The IGF-1R/IR Tyrosine Kinase Inhibitor, PQIP, Exhibits Enhanced Anti-Tumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models
  af: Flanigan, Sara A., et al.
  Udgivet: (2010)
• A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer
  af: Davis, S. Lindsey, et al.
  Udgivet: (2018)
• Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer
  af: Pitts, Todd M., et al.
  Udgivet: (2014)